AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionCAPROCK Group, Inc.
Latest Disclosed Ownership62,485 shares
Latest Disclosed Value $ 13,589,961
CAPROCK Group, Inc. reports 1.38% increase in ownership of ABBV / AbbVie Inc.

On May 11, 2026 - CAPROCK Group, Inc. filed a 13F-HR form disclosing ownership of 62,485 shares of AbbVie Inc. (US:ABBV) valued at $13,589,863 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 61,633 shares of AbbVie Inc.. This represents a change in shares of 1.38% during the quarter. The current value of the position is $13,567,368 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ABBVIE COM 00287Y109 62,485 852 1.38 13,590 -3.50 0.3299
2026-01-28 2025-12-31 13F ABBVIE COM 00287Y109 61,633 3,201 5.48 14,083 14.54 0.2975
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 58,432 7,835 15.49 12,294 15.97 0.3028
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 50,597 7,776 18.16 10,601 39.32 0.3233
2025-01-23 2024-12-31 13F ABBVIE COM 00287Y109 42,821 1,624 3.94 7,609 -6.47 0.2487
2024-11-07 2024-09-30 13F ABBVIE COM 00287Y109 41,197 3,747 10.01 8,136 26.65 0.2960
2024-08-06 2024-06-30 13F ABBVIE COM 00287Y109 37,450 15,382 69.70 6,423 59.86 0.2612
2024-04-29 2024-03-31 13F ABBVIE COM 00287Y109 22,068 2,498 12.76 4,019 32.52 0.2304
2024-01-18 2023-12-31 13F ABBVIE COM 00287Y109 19,570 3,143 19.13 3,033 23.86 0.1938
2023-10-18 2023-09-30 13F ABBVIE COM 00287Y109 16,427 287 1.78 2,449 12.60 0.1853
2023-08-10 2023-06-30 13F ABBVIE COM 00287Y109 16,140 -2,232 -12.15 2,175 -25.75 0.1597
2023-04-26 2023-03-31 13F ABBVIE COM 00287Y109 18,372 2,265 14.06 2,928 12.49 0.2269
2023-01-23 2022-12-31 13F ABBVIE COM 00287Y109 16,107 -2,179 -11.92 2,603 6.07 0.2423
2022-11-07 2022-09-30 13F ABBVIE COM 00287Y109 18,286 -728 -3.83 2,454 -15.73 0.2363
2022-07-26 2022-06-30 13F ABBVIE COM 00287Y109 19,014 672 3.66 2,912 -2.05 0.2857
2022-04-12 2022-03-31 13F ABBVIE COM 00287Y109 18,342 -1,227 -6.27 2,973 12.19 0.2794
2022-01-18 2021-12-31 13F ABBVIE COM 00287Y109 19,569 -3,315 -14.49 2,650 7.33 0.2185
2021-10-07 2021-09-30 13F ABBVIE COM 00287Y109 22,884 2,953 14.82 2,469 9.98 0.2206
2021-08-13 2021-06-30 13F ABBVIE COM 00287Y109 19,931 -2,420 -10.83 2,245 -7.19 0.2043
2021-04-29 2021-03-31 13F ABBVIE COM 00287Y109 22,351 -6,582 -22.75 2,419 -21.97 0.2645
2021-01-29 2020-12-31 13F ABBVIE COM 00287Y109 28,933 -2,161 -6.95 3,100 13.80 0.3535
2020-10-29 2020-09-30 13F ABBVIE COM 00287Y109 31,094 -2,231 -6.69 2,724 -16.75 0.3728
2020-08-05 2020-06-30 13F ABBVIE COM 00287Y109 33,325 9,131 37.74 3,272 77.54 0.4916
2020-04-28 2020-03-31 13F ABBVIE COM 00287Y109 24,194 3,561 17.26 1,843 0.88 0.3490
2020-02-04 2019-12-31 13F ABBVIE COM 00287Y109 20,633 876 4.43 1,827 22.13 0.3268
2019-10-31 2019-09-30 13F ABBVIE COM 00287Y109 19,757 6,132 45.01 1,496 50.96 0.2920
2019-07-23 2019-06-30 13F ABBVIE COM 00287Y109 13,625 -429 -3.05 991 -12.53 0.1937
2019-04-12 2019-03-31 13F ABBVIE COM 00287Y109 14,054 1,379 10.88 1,133 -3.08 0.2201
2019-01-29 2018-12-31 13F ABBVIE COM 00287Y109 12,675 904 7.68 1,169 5.03 0.2691
2018-10-17 2018-09-30 13F ABBVIE COM 00287Y109 11,771 -420 -3.45 1,113 -1.42 0.2263
2018-07-23 2018-06-30 13F ABBVIE COM 00287Y109 12,191 -4,288 -26.02 1,129 -27.63 0.2388
2018-04-23 2018-03-31 13F ABBVIE COM 00287Y109 16,479 -1,491 -8.30 1,560 -14.10 0.3330
2018-01-17 2017-12-31 13F ABBVIE COM 00287Y109 17,970 -2,002 -10.02 1,816 2.31 0.3533
2017-10-23 2017-09-30 13F ABBVIE COM 00287Y109 19,972 -1,916 -8.75 1,775 11.85 0.3698
2017-07-27 2017-06-30 13F ABBVIE COM 00287Y109 21,888 3,085 16.41 1,587 29.55 0.3525
2017-04-21 2017-03-31 13F ABBVIE COM 00287Y109 18,803 -4,287 -18.57 1,225 -15.28 0.2878
2017-01-24 2016-12-31 13F ABBVIE COM 00287Y109 23,090 -11,866 -33.95 1,446 -34.42 0.3639
2016-11-15 2016-09-30 13F ABBVIE COM 00287Y109 34,956 320 0.92 2,205 2.85 0.5002
2016-08-25 2016-06-30 13F ABBVIE COM 00287Y109 34,636 -1,800 -4.94 2,144 3.03 0.5227
2016-05-11 2016-03-31 13F ABBVIE COM 00287Y109 36,436 36,436 2,081 0.4934
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.